Vous participez à AFRAVIH? Si oui, ne manquez pas notre symposium « Transformer la réponse mondiale au VIH et ses co-infections en accélérant l’accès aux innovations en santé pour tous » ! #AFRAVIH2024 📅16 avril 15h30 📍 salle 4/E Plus d'infos : livebyglevents.key4register.com/key4register/p…

If you are a doctor/other prescriber working in an African country, please fill in this 10 min survey on fungal diagnostics&drugs for a chance to win attendance at the AIDS Mycoses conference in Cape Town, 2024! Please retweet! surveymonkey.com/r/SGULAFS2024

Stepping out of the fungal comfort zone to discuss women #empowerment at scientific ID/CM conferences. 🙏🏻 ESCMID for making this a priority. 🙏🏻 to the MicroID EmpowHERment consortium. Join us ! #ESCMIDGlobal2024 #WomenInSTEM

A huge amount of work. An outstanding PhD defense Mycology Department - Institut Pasteur Institut Pasteur, since 1887 . Congratulations Clara BEKIRIAN 👩🏻‍🎓🍄, you did!

Registration details bit.ly/MMSN2024

Thanks to the Translational Research Lab, IDI, Kampala Felix Bongomin, MD MSc Infectious Diseases Institute, Makerere University @mukashyakaClau5 for hosting me for one day of experiment. Thanks IMMY and Diego Cáceres for the EIA Histoplasma.

Many thanks MSF International Épicentre Mbarara Dan Nyehangane and his great time. A amazing week with you.

🆕📰 Risk factors and outcome associated with #fungal 🍄 infections in patients with severe #burn injury 🔥 → Our 10 year IFI-BURN from Hôpital Saint-Louis AP-HP study with Emmanuel Dudoignon just out in Clinical Infectious Diseases Stay tuned, more to come… ! In long 👉 doi.org/10.1093/cid/ci… In short👇

In settings with a low prevalence of histoplasmosis, screening people with advanced HIV disease but no compatible signs/symptoms (cf CrAg screening) seems inadvisable - low PPV In this study, 7.5% (3/40) "control" patients tested HAg LFA+ (MiraVista). Untreated & remained well.

It’s time to register for the Medical Mycology Course 2025 at Institut Pasteur, since 1887 pasteur.fr/en/education/p…

How to deal with and what is the impact of some recently described phenotypes in C. neoformans. See this review work from great researchers from our Pasteur group: #PLOSPathogens: Population heterogeneity in Cryptococcus neoformans: Impact on pathogenesis dx.plos.org/10.1371/journa…

3rd day at Duke University, Duke Infectious Diseases in Dr Le’s lab. Very lucky to be trained and learn more about the diagnostic of Talaromyces marneffei 🔬🍄🌏!

Just seven days left to submit your abstracts! Don't be left out of the discourse on fungal disease burden and public health impact in 🇳🇬

Depuis sa prison de Nuuk au Groenland, Paul revient sur l’urgence de sauver l’océan. #FreePaulWatson

Very inspiring work Freddy Perez ! #InFocus2024

A great talk about mold identification 🍄🔬 Dr Dea Garcia-Hermoso Alessandro Araújo Mycology Department - Institut Pasteur Institut Pasteur, since 1887

Very proud to share our collaborative paper 🇧🇷🇫🇷 with great Brazilian colleagues (especially Pasqua ) on Histo and RTqPCR screening. Dynamics of Histoplasma fungal load in people living with HIV with dis... sciencedirect.com/science/articl… Great work from all and Aude Sturny Leclère

First Medical Mycology Course 🍄🧬🔬💊🍄at IP Alger with Pr Lortholary, Dr Garcia-Hermoso, Dr Hamane and Pr Bachi Institut Pasteur, since 1887 Mycology Department - Institut Pasteur

Thanks to Pasqua and @Ilan Schwartz for these pertinent comments in this editorial for CID. Histoplasma Ag screening in PLHIV WO symptoms: ✅ or ❌? #histoplasmosis #hiv #aids

#ISHAM coming to 🌍 in 2028! Brilliant presentation by Rita Oladele telling everyone what to expect! Congratulations to Pan African Mycology Working Group and all African mycologists! Let's make it historic!